Takatsuki, Japan

Norihisa Kikuchi

This inventor holds 1 USPTO granted patent. Top assignee: Shionogi Company Limited. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Norihisa Kikuchi. Retrieved from https://idiyas.com/inventor/norihisa-kikuchi-p66dupcn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Norihisa Kikuchi: Innovator in Biochemistry

Introduction

Norihisa Kikuchi is a prominent inventor based in Takatsuki, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of modified human pancreatic secretory trypsin inhibitors. His work has implications for various medical and therapeutic applications.

Latest Patents

Kikuchi holds a patent for a modified human pancreatic secretory trypsin inhibitor. This patent includes DNA sequences encoding modified varieties of human PSTI that possess excellent stability. These modified varieties show decreased susceptibility to decomposition by proteolytic enzymes such as trypsin, compared to natural human PSTI. The patent highlights the innovative approach to enhancing the stability and efficacy of these important biological molecules.

Career Highlights

Norihisa Kikuchi is associated with Shionogi Company Limited, a well-respected pharmaceutical company. His work at Shionogi has allowed him to focus on research and development in biochemistry, contributing to advancements in medical science.

Collaborations

Kikuchi has collaborated with notable colleagues, including Nobuo Yoshida and Masaru Shin. These collaborations have fostered a productive research environment, leading to innovative solutions in their field.

Conclusion

Norihisa Kikuchi's contributions to biochemistry, particularly through his patented work on modified human pancreatic secretory trypsin inhibitors, demonstrate his commitment to advancing medical science. His collaborations and career at Shionogi Company Limited further highlight his impact in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…